IPO

The French REIT posts strong Q1 growth by doubling down on prime central assets, revealing a stark divide in the Paris real estate landscape.

The diabetes tech firm posted a 57% revenue jump and lifted its 2026 outlook, but a sequential drop in new users raises questions for investors.

The NYC-based bank doubles its profit and raises nearly $200M, signaling aggressive growth plans and boosting shareholder confidence with a dividend hike.

The owner of Men's Wearhouse confidentially files for an IPO, signaling a major comeback after its 2020 bankruptcy. What's behind the strategic move?

The advanced materials firm plans a SPAC merger to scale its 'Atomic Armor' nanocoating, aiming to secure U.S. tech sovereignty in AI and defense.

Adocia extends its cash runway to 2027 with a new loan, but the deal could make its key investor the largest shareholder, creating a dilution dilemma.

The private jet firm reports impressive top-line growth, but SEC filings reveal widening losses and raise serious questions about its path to profitability.

Talisker Resources triples its Bralorne drill program, aiming to secure future production and explore new gold frontiers in a historic BC mining camp.

As institutional money and new regulations professionalize crypto, firms like True are launching specialized practices to find the new breed of executive talent.

Biotech firm Northwest Biotherapeutics is opening a private clinic to speed up cancer therapy access, a strategic move to control its supply chain.

Digital Brands Group launches AVO apparel with Vanderbilt, tapping the NIL market. But can a struggling company score a win in the big leagues of college sports?

A new venture led by tech veteran David Gurlé aims to build AI infrastructure 5x faster and 50% cheaper by bringing micro data centers to the energy source.

A new partnership brings enterprise-grade email signature governance to the channel, offering MSPs a recurring revenue stream and a unique compliance edge.

A new scholarship from Antech & Vet Set Go offers funds and mentorship to aspiring vets, aiming to ease the path and combat a growing industry shortage.

CEO Andrew Lutfy to pocket over $300 million from a massive share sale and a company-funded buyback, raising questions about capital allocation.

With a $719M war chest from its blockbuster IPO, Kailera Therapeutics is poised to challenge the dominance of Lilly and Novo in the lucrative obesity market.

As IPO markets revive, advisory firms say patient private equity capital and rigorous prep are the keys for companies hoping to go public successfully.

The bakery chain saw gross profit climb 14.2%, but a staggering 99% EPS drop and struggling U.S. stores paint a complex picture for investors.

With the AI market set to hit $3.5T, Alpha Compute launches with a mission to provide secure, private infrastructure for the world's most sensitive data.

With a new world-class exploration VP and a bullish gold market, Blossom Gold is aggressively pushing to unlock a 1.28M ounce gold deposit in Nevada.